We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Stock Spirits Group PLC
STCK:LSE
258.90
GBX
+0.60
+0.23%
Riverstone Energy Ltd
RSE:LSE
876.00
GBX
+5.50
+0.63%
Law Debenture Corporation
LWDB:LSE
526.50
GBX
+2.00
+0.38%
JD Sports Fashion PLC
JD.:LSE
466.00
GBX
+1.25
+0.27%
Dechra Pharmaceuticals PLC
DPH:LSE
808.50
GBX
+2.00
+0.25%
Hellermanntyton Group PLC
HTY:LSE
285.00
GBX
+0.70
+0.25%
Scottish Investment Trust
SCIN:LSE
619.00
GBX
+1.50
+0.24%
Infinis Energy PLC
INFI:LSE
229.80
GBX
+0.55
+0.24%
De La Rue PLC
DLAR:LSE
553.50
GBX
+1.25
+0.23%
Synthomer PLC
SYNT:LSE
222.50
GBX
+0.50
+0.23%
As of Nov 25 2014 17:16 GMT.

Companies news

Who bought who
Deal status
Deal value
Date
Aviva PLCacquiredFriends Life Group LtdAnnounced8.71bn21 Nov 2014
Bestv New Media Co LtdacquiredShanghai Oriental Pearl(Group) Co LtdAnnounced5.48bn22 Nov 2014
Kotak Mahindra Bank LtdacquiredING Vysya Bank LtdAnnounced2.40bn20 Nov 2014
RenaissanceRe Holdings LtdacquiredPlatinum Underwriters Holdings LtdAnnounced1.64bn24 Nov 2014
CitySpring Infrastructure TrustacquiredKeppel Infrastructure TrustAnnounced526.28m18 Nov 2014
1-5 of 6 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

HP profits edge lower on lacklustre sales
Washington weighs in on Google probe
Apple joins the one-company $700bn club
Total to face corruption trial in France
Tiffany cuts sales outlook as Asia slows

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply